Strain differences influence murine pulmonary responses to Stachybotrys chartarum

American Journal of Respiratory Cell and Molecular Biology

Volumn 35, Issue 4, 2006, Pages 415-423

  Lichtenstein, Jamie H Rosenblum ^a   Molina, Ramon M ^a   Donaghey, Thomas C ^a   Brain, Joseph D ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

BALB c; C57BL 6; Cytokines; Lung diseases, fungal; Mold

Indexed keywords

ALBUMIN; ALLERGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; HEMOGLOBIN; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; KERATINOCYTE DERIVED CYTOKINE; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 1GAMMA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MYCOTOXIN; MYELOPEROXIDASE; OVALBUMIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC INFLAMMATION; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FUNGUS SPORE; GENETIC DIFFERENCE; INFLAMMATION; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; MOUSE STRAIN; MYCOSIS; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROTECTION; STACHYBOTRYS CHARTARUM; STRAIN DIFFERENCE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOGLOBINS; INSULIN; LUNG DISEASES, FUNGAL; MICE; MICE, INBRED STRAINS; PNEUMONIA; RESPIRATORY HYPERSENSITIVITY; SERUM ALBUMIN; SPECIES SPECIFICITY; STACHYBOTRYS; TOLL-LIKE RECEPTOR 4;

FUNGI; MAMMALIA; MURINAE; STACHYBOTRYS; STACHYBOTRYS CHARTARUM;

EID: 33749174268     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0483OC     Document Type: Article

References (84)

1. Burge HA. Airborne allergenic fungi: classification, nomenclature, and distribution. Immunol Allergy Clin North Am 1989;9:307-319.
2. Larsen FO, Christensen LH, Clementsen P, Gravesen S, Stahl Skov P, Norn S. Microfungi in indoor air are able to trigger histamine release by non-IgE-mediated mechanisms. Inflamm Res 1996;45:S23-S24.
3. Rylander R, Persson K, Goto H, Yuasa K, Tanaka S. Airborne beta-1,3 glucan may be related to symptoms in sick buildings. Indoor Environ 1992;1:263-267.
4. Flannigan B. Mycotoxins in the air. Int Biodeterior 1987;23:73-78.
5. Hendry KM, Cole EC. A review of mycotoxins in indoor air. J Toxicol Environ Health 1993;38:183-198.
6. Sorenson W. Mycotoxins as potential occupational hazards. Dev Ind Microbiol 1990;31:205-211.
7. Cooley JD, Wong WC, Jumper CA, Straus DC. Correlation between the prevalence of certain fungi and sick building syndrome. Occup Environ Med 1998;55:579-584.
8. Croft WA, Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atmos Environ 1986;20:549-552.
9. Hintikka EL. Human stachybotryotoxicosis. In: Wyllie T, Morehouse L, editors. Mycotoxic fungi, mycotoxins and mycotoxicosis. New York: Marcel Dekker; 1978. pp. 87-89.
10. Sudakin DL. Toxigenic fungi in a water-damaged building: an intervention study. Am J Ind Med 1998;34:183-190.
11. Etzel RA, Montana E, Sorenson WG, Kullman GJ, Allan TM, Dearborn DG, Olson DR, Jarvis BB, Miller JD. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 1998;152:757-762.
12. Dearborn DG, Yike I, Sorenson WG, Miller MJ, Etzel RA. Overview of investigations into pulmonary hemorrhage among infants in Cleveland, Ohio. Environ Health Perspect 1999;107:495-499.
13. Drannik AG, Pouladi MA, Robbins CS, Goncharova SI, Kianpour S, Stampfli MR. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2004;170:1164-1171.
14. Gent JF, Ren P, Belanger K, Triche E, Bracken MB, Holford TR, Leaderer BP. Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma. Environ Health Perspect 2002;110:A781-A786.
15. Dill I, Niggemann B. Domestic fungal viable propagules and sensitization in children with IgE mediated allergic diseases. Pediatr Allergy Immunol 1996;7:151-155.
16. Bata A, Harrach B, Vanyi A, Lepom P. Macrocyclic trichothecene toxins produced by Stachybotrys atra. Acta Vet Hung 1988;36:221-227.
17. Jarvis BB, Lee YW, Comezoglu SN, Yatawara CS. Trichothecenes produced by Stachybotrys atra from Eastern Europe. Appl Environ Microbiol 1986;51:915-918.
18. Pasanen A, Nikulin J, Tuimainen M, Berg S, Parikka P, Hinnikka EL. Laboratory experiments on membrane filter sampline of airborne mycotoxins produced by Stachybotrys atra Corda. Atmos Environ 1993;27A:9-13.
19. Sorenson WG, Frazer DG, Jarvis BB, Simpson J, Robinson VA. Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra. Appl Environ Microbiol 1987;53:1370-1375.
20. Ueno Y. Mode of action of trichothecenes. Ann Nutr Aliment 1977;31:885-900.
21. Vesper SJ, Magnuson ML, Dearborn DG, Yike I, Haugland RA. Initial characterization of the hemolysin stachylysin from Stachybotrys chartarum. Infect Immun 2001;69:912-916.
22. Vesper SJ, Vesper MJ. Stachylysin may be a cause of hemorrhaging in humans exposed to Stachybotrys chartarum. Infect Immun 2002;70:2065-2069.
23. Bergmann F, Yagen B, Jarvis BB. The toxicity of macrocyclic trichothecenes administered directly into the rat brain. Toxicon 1992;30:1291-1294.
24. Bubien JK, Woods WT Jr. Direct and reflex cardiovascular effects of trichothecene mycotoxins. Toxicon 1987;25:325-331.
25. Glavits R, Vanyi A. Effect of trichothecene mycotoxins (satratoxin H and T-2 toxin) on the lymphoid organs of mice. Acta Vet Hung 1988;36:37-41.
26. Hughes BJ, Hsieh GC, Jarvis BB, Sharma RP. Effects of macrocyclic trichothecene mycotoxins on the murine immune system. Arch Environ Contam Toxicol 1989;18:388-395.
27. Ohff R, Kwella M, Booth W. Studies into Stachybotrys atra: use of skin test on rats for verification of toxicity. Monatsh Veterinaermed 1985;40:774-776.
28. Schiefer HB, Hancock DS, Bhatti AR. Systemic effects of topically applied trichothecenes. I. Comparative study of various trichothecenes in mice. Zentralbl Veterinarmed A 1986;33:373-383.
29. Yoshizawa T, Ohtsubo K, Sasaki T, Nakamura K. Acute toxicities of satratoxins G and H in mice - a histopathological observation with special reference to the live injury caused by satratoxin G. Proc Jap Assoc Mycotoxicol 1986;23:53-57.
30. Nikulin M, Reijula K, Jarvis BB, Hintikka EL. Experimental lung mycotoxicosis in mice induced by Stachybotrys atra. Int J Exp Pathol 1996; 77:213-218.
31. Nikulin M, Reijula K, Jarvis BB, Veijalainen P, Hintikka EL. Effects of intranasal exposure to spores of Stachybotrys atra in mice. Fundam Appl Toxicol 1997;35:182-188.
32. Rao CY, Burge HA, Brain JD. The time course of responses to intratracheally instilled toxic Stachybotrys chartarum spores in rats. Mycopathologia 2000;149:27-34.
33. Viana ME, Coates NH, Gavett SH, Selgrade MK, Vesper SJ, Ward MD. An extract of Stachybotrys chartarum causes allergic asthma-like responses in a BALB/c mouse model. Toxicol Sci 2002;70:98-109.
34. Le Bars J, Le Bars P. Etude du nuage de spores de Stachybotrys atra contaminant de pailles: risques d'inhalation. Bull Soc Fr Mycol Med 1985;14:321-324.
35. Le Bars J, Le Bars P. Toxinogenesis and development conditions of Stachybotrys atra in France. Acta Vet Scand Suppl 1991;87:349-351.
36. Meier A, Kirschning CJ, Nikolaus T, Wagner H, Heesemann J, Ebel F. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003;5:561-570.
37. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
38. Taconic Guide to Products and Services. Germantown, NY: Taconic; 2003. pp. 23-25.
39. Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, Yoshikai Y. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol 2003; 10:259-266.
40. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002;2:845-858.
41. Taborda CP, Juliano MA, Puccia R, Franco M, Travassos LR. Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun 1998;66:786-793.
42. Magee DM, Friedberg RL, Woitaske MD, Johnston SA, Cox RA. Role of B cells in vaccine-induced immunity against coccidioidomycosis. Infect Immun 2005;73:7011-7013.
43. Su SH, Chen H, Jen CJ. C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise. J Immunol 2001;167:5084-5091.
44. Brain JD, Knudson DE, Sorokin SP, Davis MA. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res 1976;11:13-33.
45. Leong BK, Coombs JK, Sabaitis CP, Rop DA, Aaron CS. Quantitative morphometric analysis of pulmonary deposition of aerosol particles inhaled via intratracheal nebulization, intratracheal instillation or nose-only inhalation in rats. J Appl Toxicol 1998;18:149-160.
46. Henderson RF. Commentary on 'Cellular and biochemical indices of bronchoalveolar lavage for detection of lung injury following insult by airborne toxicants' by M. Firoze Khan and G.S.D. Gupta. Toxicol Lett 1991;8:235-238.
47. Khan MF, Gupta GS. Cellular and biochemical indices of bronchoalveolar lavage for detection of lung injury following insult by airborne toxicants. Toxicol Lett 1991;8:239-255.
48. Beck BD, Brain JD, Bohannon DE. An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol 1982;66:9-29.
49. Blythe S, England D, Esser B, Junk P, Lemanske RF Jr. IgE antibody mediated inflammation of rat lung: histologic and bronchoalveolar lavage assessment. Am Rev Respir Dis 1986;134:1246-1251.
50. Lecours R, Laviolette M, Cormier Y. Bronchoalveolar lavage in pulmonary mycotoxicosis (organic dust toxic syndrome). Thorax 1986;41:924-926.
51. Krinzman SJ, De Sanctis GT, Cernadas M, Kobzik L, Listman JA, Christiani DC, Perkins DL, Finn PW. T cell activation in a murine model of asthma. Am J Physiol 1996;271:L476-L483.
52. Schall T. Chapter 22: The chemokines. In: Thomson A, editor. The cytokine handbook, 2nd ed. New York: Academic Press; 1994. pp. 419-460.
53. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 1994;20:473-490.
54. Heinrich JN, Bravo R. The orphan mouse receptor interleukin (IL)-8R beta binds N51. Structure-function analysis using N51/IL-8 chimeric molecules. J Biol Chem 1995;270:4987-4989.
55. Lee J, Cacalano G, Camerato T, Toy K, Moore MW, Wood WI. Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol 1995;155:2158-2164.
56. Grossblatt N, Paulson LR, editor. Biologic markers in pulmonary toxicology. Washington, DC: National Academy Press; 1989.
57. Calderon L, Williams R, Martinez M, Clemons KV, Stevens DA. Genetic susceptibility to vaginal candidiasis. Med Mycol 2003;41:143-147.
58. Cox RA, Kennell W, Boncyk L, Murphy JW. Induction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis. Infect Immun 1988;56:13-17.
59. Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997;17:733-739.
60. Magee DM, Cox RA. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun 1996;64:3609-3613.
61. Mullick A, Elias M, Picard S, Bourget L, Jovcevski O, Gauthier S, Tuite A, Harakidas P, Bihun C, Massie B, et al. Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect Immun 2004;72:5868-5876.
62. Pitarch A, Diez-Orejas R, Molero G, Pardo M, Sanchez M, Gil C, Nombela C. Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics 2001;1:550-559.
63. Stephens-Romero SD, Mednick AJ, Feldmesser M. The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun 2005;73:114-125.
64. Debs RJ, Fuchs HJ, Philip R, Montgomery AB, Brunette EN, Liggitt D, Patton JS, Shellito JE. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats. J Immunol 1988;140:3482-3488.
65. Jordan JA, Guo RF, Yun EC, Sarma V, Warner RL, Crouch LD, Senaldi G, Ulich TR, Ward PA. Role of IL-18 in acute lung inflammation. J Immunol 2001;167:7060-7068.
66. Tsutsui H, Yoshimoto T, Hayashi N, Mizutani H, Nakanishi K. Induction of allergic inflammation by interleukin-18 in experimental animal models. Immunol Rev 2004;202:115-138.
67. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005;32:311-318.
68. Randolph AG, Lange C, Silverman EK, Lazarus R, Weiss ST. Extended haplotype in the tumor necrosis factor gene cluster is associated with asthma and asthma-related phenotypes. Am J Respir Crit Care Med 2005;172:687-692.
69. Lundblad LK, Thompson-Figueroa J, Leclair T, Sullivan MJ, Poynter ME, Irvin CG, Bates JH. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med 2005;171:1363-1370.
70. Krasna E, Kolesar L, Slavcev A, Valhova S, Kronosova B, Jaresova M, Striz I. IL-18 receptor expression on epithelial cells is upregulated by TNF alpha. Inflammation 2005;29:33-37.
71. Knight D. Leukaemia inhibitory factor (LIF): a cytokine of emerging importance in chronic airway inflammation. Pulm Pharmacol Ther 2001;14:169-176.
72. Walter MJ, Holtzman MJ. A centennial history of research on asthma pathogenesis. Am J Respir Cell Mol Biol 2005;32:483-489.
73. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
74. Peters-Golden M. The alveolar macrophage: the forgotten cell in asthma. Am J Respir Cell Mol Biol 2004;31:3-7.
75. Brown GD, Gordon S. Fungal beta-glucans and mammalian immunity. Immunity 2003;19:311-315.
76. Hoag KA, Street NE, Huffnagle GB, Lipscomb MF. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995;13:487-495.
77. Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994;55:35-42.
78. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000;164:6166-6173.
79. Herre J, Willment JA, Gordon S, Brown GD. The role of Dectin-1 in antifungal immunity. Crit Rev Immunol 2004;24:193-203.
80. Jimenez-Alzate Md WL, Viriyakosol S, Fierer J. Inherited susceptibility to Coccidioides immitis in C57BL/6 mice is associated with a truncated splice variant of dectin-1. FASEB J 2005;19:A935.
81. Viriyakosol S, Fierer J, Brown GD, Kirkland TN. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun 2005;73:1553-1560.
82. Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 1997;46:33-35.
83. Centers for Disease Control and Prevention. Update: Pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep 2000;49:180-184.
84. Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. JAMA 2000;283:1951-1953.